Mitotic abnormalities and spindle assembly checkpoint inactivation in a cell model of Shwachman-Diamond syndrome with mutations in the Shwachman-Bodian-Diamond syndrome gene, 258+2T > C.

Shwachman-Diamond syndrome chromosomal instability mitosis spindle assembly checkpoint

Journal

Drug discoveries & therapeutics
ISSN: 1881-784X
Titre abrégé: Drug Discov Ther
Pays: Japan
ID NLM: 101493809

Informations de publication

Date de publication:
26 Oct 2024
Historique:
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 27 10 2024
Statut: aheadofprint

Résumé

Hematologic abnormalities are the most common symptoms of Shwachman-Diamond syndrome (SDS). The causative gene for SDS is the Shwachman-Bodian-Diamond syndrome (SBDS) gene; however, the function of SBDS and pathogenesis of each condition in SDS are largely unknown. SBDS is known to be localized at mitotic spindles and stabilizes microtubules. Previously, we demonstrated that SBDS is ubiquitinated and subsequently degraded in the mitotic phase, thereby accelerating mitotic progression. In this study, we examined mitosis in a myeloid cell model of SDS (SDS cells). 4',6-Diamidino-2-phenylindole (DAPI)-stained chromosome observation and cell cycle analysis of nocodazole-synchronized cells revealed that the SDS cells have abnormally rapid mitosis. In addition, many lagging chromosomes and micronuclei were detected. Moreover, the phosphorylation of threonine tyrosine kinase, the crucial kinase of the spindle assembly checkpoint (SAC), was suppressed. Chromosomal instability caused by SAC dysfunction may cause a variety of clinical conditions, including hematologic tumors in patients with SDS.

Identifiants

pubmed: 39462584
doi: 10.5582/ddt.2024.01070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yukihiro Sera (Y)

Laboratory of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, Japan.

Tsuneo Imanaka (T)

Laboratory of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, Japan.

Yusuke Iguchi (Y)

Laboratory of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, Japan.

Masafumi Yamaguchi (M)

Laboratory of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, Japan.

Classifications MeSH